Home Biosimilar Antibodies Protein Tyrosine Kinase PDGFR Rinucumab (Anti-PDGFRB / CD140b) For research use only.
Not for use in humans.

Rinucumab (Anti-PDGFRB / CD140b)

Synonyms: REGN 2176

Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.

Rinucumab (Anti-PDGFRB / CD140b)

Purity & Quality Control

≥99

Choose Selective PDGFR Inhibitors

Biological Activity

Description Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.

Product Details

CAS No. 1569263-06-4
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) supplier | purchase Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) cost | Rinucumab (Anti-PDGFRB / CD140b) manufacturer | order Rinucumab (Anti-PDGFRB / CD140b) | Rinucumab (Anti-PDGFRB / CD140b) distributor